4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001000229-17-000029
CIK 0001000229operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:53 PM ET
Size
6.0 KB
Accession
0001000229-17-000029
Insider Transaction Report
Form 4
DEMSHUR DAVID M
DirectorChief Executive Officer
Transactions
- Award
Restricted Performance Shares
2017-02-14+39,400→ 39,400 totalExercise: $0.00→ Common Shares (39,400 underlying)
Footnotes (1)
- [F1]Assuming a recipient's continued employment (or death/disability while employed) and the satisfaction of certain performance goals is achieved, these awards would vest at the end of a 3-year performance period that began on 1/1/17 and ends on 12/31/19 (the "Performance Period"). At the end of the Performance Period, 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG, all as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. The award will be extrapolated on a straight line basis between the 50th and 100th percentile. If the minimum criterion is not met, then no shares shall vest and the award shall be forfeited.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:53 PM ET
- Size
- 6.0 KB